Safety, Tolerability And Mechanism Of Action Of Boswellic Acids (BA) In Multiple Sclerosis (SABA)
Status:
Completed
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
To determine the safety and tolerability of BOSWELAN in subjects with multiple sclerosis or
clinically isolated syndrome and to describe the effect of Boswellic acids on the disease
activity as assessed by monthly MRI measures.